Earlier today President Trump signed S. 204, the “Right to Try Act”. The legislation provides terminally ill patients with the right to try experimental medicine and medical procedures. Detail: authorizes certain patients to seek access to certain unapproved investigational drugs directly from a drug sponsor or manufacturer; limits the use of clinical outcomes and liability arising from the provision of such drugs; and provides reporting requirements for the use and outcomes of the new authority.
[Transcript] 12:31 P.M. EDT – THE PRESIDENT: Thank you very much, everybody. I really appreciate it. This is — to me, this is a very important moment, a very important day. Been looking forward to this for a long time, along with Senator Ron Johnson. And I will tell you, we worked hard on this. I never understood why it was hard.




